Mersana Therapeutics (MRSN) P/E (2017 - 2026)
Mersana Therapeutics (MRSN) P/E from Jun 28, 2017 to Jan 6, 2026. The TTM Mersana Therapeutics (MRSN) P/E is -2.04. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Mersana Therapeutics (MRSN)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.04 | +0.52% |
| 2025 | -2.03 | -18.99% |
| 2024 | -2.50 | +87.56% |
| 2023 | -1.33 | -46.46% |
| 2022 | -2.49 | -4.94% |
| 2021 | -2.62 | -86.31% |
| 2020 | -19.15 | +102.71% |
| 2019 | -9.45 | +543.44% |
| 2018 | -1.47 | -92.59% |
| 2017 | -19.81 | N/A |
Comparison Mersana Therapeutics (MRSN) P/E with competitors
Mersana Therapeutics (MRSN) P/E is -2.04.